Matrix metalloproteinases as therapeutic targets in arthritic diseases: bull's-eye or missing the mark?
about
Transcriptional repression of MMP-1 by p21SNFT and reduced in vitro invasiveness of hepatocarcinoma cellsDrugs in development: bisphosphonates and metalloproteinase inhibitorsThe triterpenoid CDDO inhibits expression of matrix metalloproteinase-1, matrix metalloproteinase-13 and Bcl-3 in primary human chondrocytesPhysiological loading of joints prevents cartilage degradation through CITED2Regulatory polymorphisms in extracellular matrix protease genes and susceptibility to rheumatoid arthritis: a case-control study.Prevention of progressive joint destruction in collagen-induced arthritis in rats by a novel matrix metalloproteinase inhibitor, FR255031.Metalloproteinases: their role in arthritis and potential as therapeutic targets.Anti-Inflammatory mechanisms of the proteinase-activated receptor 2-inhibiting peptide in human synovial cells.Overexpression of human matrix metalloproteinase-12 enhances the development of inflammatory arthritis in transgenic rabbitsExpression of matrix metalloproteinases in patients with Wegener's granulomatosis.Dual effects of 17beta-oestradiol on interleukin 1beta-induced proteoglycan degradation in chondrocytes.Induction of multiple matrix metalloproteinases in human dermal and synovial fibroblasts by Staphylococcus aureus: implications in the pathogenesis of septic arthritis and other soft tissue infectionsMatrix metalloproteinases in cancer: comparison of known and novel aspects of their inhibition as a therapeutic approach.Hyaluronan Oligosaccharides Induce MMP-1 and -3 via Transcriptional Activation of NF-κB and p38 MAPK in Rheumatoid Synovial FibroblastsWhat are the roles of metalloproteinases in cartilage and bone damage?New biochemical insights into the pathogenesis of osteoarthritis and the role of laboratory investigations in clinical assessment.Is collagenase-3 (MMP-13) expression in chondrosarcoma of the jaws a true marker for tumor aggressiveness?Matrix metalloproteases: underutilized targets for drug deliveryInhibitory effect of midazolam on MMP-9, MMP-1 and MMP-13 expression in PMA-stimulated human chondrocytes via recovery of NF-κB signaling.The pathogenic role of angiogenesis in rheumatoid arthritis.Investigation of MMP-1 genetic polymorphisms and protein expression and their effects on the risk of Kashin-Beck disease in the northwest Chinese Han population.Inhibition of matrix metalloproteinases enhances in vitro repair of the meniscusInhibition of integrative repair of the meniscus following acute exposure to interleukin-1 in vitroCollagenase-3 (MMP-13) deficiency protects C57BL/6 mice from antibody-induced arthritis.Cinnamophilin isolated from Cinnamomum philippinense protects against collagen degradation in human chondrocytes.Regulated and constitutive expression of anti-inflammatory cytokines by nontransforming herpesvirus saimiri vectors.Thymoquinone inhibits matrix metalloproteinase expression in rabbit chondrocytes and cartilage in experimental osteoarthritis.Sulfasalazine blocks the release of proteoglycan and collagen from cytokine stimulated cartilage and down-regulates metalloproteinases.Relative messenger RNA expression profiling of collagenases and aggrecanases in human articular chondrocytes in vivo and in vitro.Anti-inflammatory activity of green versus black tea aqueous extract in a rat model of human rheumatoid arthritis.Astaxanthin ameliorates cartilage damage in experimental osteoarthritis.Anti-inflammatory and chondroprotective effects of atorvastatin in a cartilage explant model of osteoarthritis.Salutary effects of melatonin combined with treadmill exercise on cartilage damage.Chitosan oligosaccharides inhibit IL-1β-induced chondrocyte apoptosis via the P38 MAPK signaling pathway.
P2860
Q24306381-2E69EFF4-B7C7-44A9-86F6-8C63FA304729Q24795847-26474A96-3F01-4920-98EF-F4F7871DD3A8Q24797661-F9FFCCA2-08B0-498B-9F77-72C56F2B61EEQ28581964-EE499670-9EC0-4164-97B8-0416440FE8B6Q34896489-2CF775B6-AB3C-4938-BF73-C1AC3F388120Q35048514-F4E5BC24-C6FF-44DA-AAC7-DCA09AD83950Q35056019-B06F21D0-EF5D-4CC9-B11B-37A22CAF692BQ35102739-FE7DAF08-C325-4D53-A62D-1217B3C9A0E4Q35103192-646E5F7E-B68A-4BCB-B1A6-885A825915EBQ35553707-7B4466C0-006D-4D4C-8B69-B4ADB025203BQ35553815-844E05FA-CDAA-41F1-A9E9-35F086BCE8FDQ35630077-54799A37-B4CA-49A6-B598-84219BEAA94CQ36066182-15494AEC-13C9-4E69-B5E9-19E32E93F59AQ36114300-52F1C932-D897-4DB4-9846-8BFD3B53F727Q36292638-84476288-3207-40A7-AC0D-78F9254CCE65Q36310851-7E4531CD-7845-48C1-A1A2-E6F99BDAEE78Q36742135-04E4F16D-E3E5-4223-8FF9-15C534CA675EQ36761849-8DA3C19E-D711-437F-A450-9D4CB967D4B3Q36828998-CF1C1793-0F89-47A0-B378-9BBACF704467Q36934777-39D4A935-C997-41AD-995B-7C322D5EE5E1Q36955186-74039CDA-6377-4240-8B7F-85D3AAD953CDQ37171756-4F81C2A5-81EB-43E6-BB3E-AB16FA999BEBQ37312764-457AF59B-B505-4B56-8341-10D5D3F9AF76Q38652392-D241A0EF-BF84-41A1-A420-6D9EB069BFBAQ39295136-13244B1D-59E5-41E6-9A85-7727CB3AA101Q40454852-97455BB0-5EC9-4F10-BDC6-8BBC47492A09Q42787065-6AB9F536-EF71-46F9-A341-34B366E37402Q43290053-FC9DAED8-9FB1-425B-90E1-C9520493F068Q44183277-9694C300-4A6C-4166-AF8F-2329A27E224EQ46617228-FB3AEEC5-06E8-4D05-A734-06D8B801A878Q50453240-EA8D8A54-578F-4541-9EAE-6D3C6973B829Q52974832-4CE662C3-D5D9-4B2D-8885-F1C7B926D3BDQ53554187-2E7AB668-4E01-41DE-B326-6E76766C6DC2Q54194592-990C4557-8FAA-4073-910A-054075FEAB64
P2860
Matrix metalloproteinases as therapeutic targets in arthritic diseases: bull's-eye or missing the mark?
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Matrix metalloproteinases as t ...... ull's-eye or missing the mark?
@ast
Matrix metalloproteinases as t ...... ull's-eye or missing the mark?
@en
Matrix metalloproteinases as t ...... ull's-eye or missing the mark?
@nl
type
label
Matrix metalloproteinases as t ...... ull's-eye or missing the mark?
@ast
Matrix metalloproteinases as t ...... ull's-eye or missing the mark?
@en
Matrix metalloproteinases as t ...... ull's-eye or missing the mark?
@nl
prefLabel
Matrix metalloproteinases as t ...... ull's-eye or missing the mark?
@ast
Matrix metalloproteinases as t ...... ull's-eye or missing the mark?
@en
Matrix metalloproteinases as t ...... ull's-eye or missing the mark?
@nl
P2093
P2860
P1476
Matrix metalloproteinases as t ...... ull's-eye or missing the mark?
@en
P2093
Constance E Brinckerhoff
John A Mengshol
Kimberlee S Mix
P2860
P356
10.1002/1529-0131(200201)46:1<13::AID-ART497>3.0.CO;2-S
P577
2002-01-01T00:00:00Z